1. IDF Diabetes Atlas, wydanie 6, dotęp:https://www.idf.org/sites/ default/files/EN_6E_Atlas_Full_0.pdf

2. Koalicja na Rzecz Walki z Cukrzycą, Niebieska Księga Cukrzycy, Warszawa 2013, http://koalicja-cukrzyca.pl/docs/ blue_paper_raport_cukrzyca_to.pdf.pdf

3. Malecki M (red. nacz.) i wsp. Zalecenia kliniczne dotyczące postępowania u chorych na cukrzycę 2015. Diabetologia Kliniczna, t. 4, suplement A.

4. Lindström J, Louheranta A, Mannelin M i wsp. Finnish Diabetes Prevention Study Group The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care 2003; 26 (12): 32303-236.

5. Diabetes Prevention Program Research Group. Knowler WC, Fowler SE, Hamman RF i wsp. 10-year follow- up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009 Nov 14;374(9702):1677-86.

6. Li G, Zhang P, Wang J i wsp. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet. 2008 May 24;371(9626):1783-9.

7. Diabetes prevention program (DPP): Type 2 diabetes and prediabetes [Internet] Bethesda, MD: National Diabetes Information Clearinghouse; 2013. Sep 09, dostęp: http://diabetes. niddk.nih.gov/dm/pubs/preventionprogram/

8. Assal JP, Mühlhauser I, Pernet A i wsp. Patient education as the basis for diabetes care in clinical practice and research. Diabetologia 1985; 28: 602-13.

9. Domenech MI, Assad D, Mazzei ME i wsp. Evaluation of the effectiveness of an ambulatory teaching/treatment programme for non-insulin dependent (type 2) diabeti patients. Acta Diabetol 1995; 32: 143-7.

10. Badurek S. Leczenie niefarmakologiczne – dieta i wysiłek fizyczny”. W: Piatkiewicz P. (red.) Leczenie osób chorych na cukrzycę w wieku podeszłym.Wydawnictwo Lekarskie PZWL. Warszawa 2015: 17-45.

11. Kirkman MS, Briscoe VJ, Clark N i wsp. Diabetes in older adults. Diabetes Care 2012; 35: 2650-2664.

12. Darmon P. Intentional weight loss in older adults: useful or wasting desease generating strategy ? Current opinion in Clinical Nutrition and Metabolic Care 2013; 16: 284-289.

13. Colberg SL, Sigal RJ, Fernhall B i wsp. Exercise and Type 2 Diabetes. Daibetes Care 2010; 33: 147-165.

14. Nathan DM, Buse JB, Davidson MB i wsp. American Diabetes Association; European Association for the Study of Diabetes. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2009;52: 17–30 pmid:18941734.

15. Selvin E, Bolen S, Yeh H-C i wsp. Cardiovascular outcomes in trials of oral diabetes medications: a systematic review. Arch Intern Med 2008;168:2070-2080.

16. A. J. Karter, M. M. Parker. Barriers to Insulin Initiation. Th eTranslatingResearchIntoActionforDiabetesInsulinStartsProje ct. Diabetes Care April 2010 vol. 33; no. 4: 733-735.

17. Inzucchi SE, Bergenstal RM, Buse JB i wsp. American Diabetes Association (ADA) European Association for the Study of Diabetes (EASD) Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012 Jun;35(6):1364–79. doi: 10.2337/dc12-0413

18. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 1998 Sep 12;352(9131):837–53.

19. Brown JB, Nichols GA. Perry A. The burden of treatment failure in type 2 diabetes. Diabetes Care 2004 Jul;27(7):1535-40.

20. Simonson DC. Etiology and prevalence of hypertension in diabetic patients. Diabetes Care 1998; 11:821–827.